Почетна › Гојазност › Merilend
Kliničke studije za Гојазност u državi Merilend
52 studija za Гојазност traži učesnike na lokacijama u državi Merilend.
Gradovi u državi Merilend
Zvanični tekst studije (na engleskom)
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Flourish Research, Bowie
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 9. 11. 2026. · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Baltimore VA Medical Center, Baltimore
- Johns Hopkins University School of Nursing, Baltimore
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351045A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Beltsville
- Research Site, Oxon Hill
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centennial Medical Group, Columbia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
- Research Site, Brooklyn
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 9. 11. 2026. · NCT07511205Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникЗдраве особе су добродошле
Узраст од 21 до 75 · Жене · Ажурирано 5. 11. 2026. · NCT03288207A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 1 до 100 · Оба пола · Ажурирано 4. 11. 2026. · NCT01143454A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Dermatology and Skin Cancer Specialists, LLC, Rockville
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Johns Hopkins Children's Center, Baltimore
Тражи се учесникФаза 3
Узраст од 6 до 11 · Оба пола · Ажурирано 4. 11. 2026. · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Centennial Medical Group, Columbia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Centennial Medical Group, Columbia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Capital Digestive Care - Chevy Chase, Chevy Chase
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Bowie, Bowie
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Capital Digestive Care - Chevy Chase, Chevy Chase
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Johns Hopkins Children's Center, Baltimore
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесник
Узраст од 18 до 50 · Оба пола · Ажурирано 2. 11. 2026. · NCT06325722Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- Johns Hopkins University, Baltimore
- Metropolitan Cardiovascular Consultants LLC, Beltsville
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459Diabetes and Heart Disease Risk in Blacks
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 70 · Оба пола · Ажурирано 29. 10. 2026. · NCT00001853Children s Growth and Behavior Study
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студијаЗдраве особе су добродошлеНаводи исплату за учеснике
Узраст од 8 до 100 · Оба пола · Ажурирано 29. 10. 2026. · NCT02390765A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Beltsville
- Research Site, Lanham
- Research Site, Oxon Hill
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- Parexel International-EPCU Baltimore, Baltimore
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT06842186Evaluation of Children With Endocrine and Metabolic-Related Conditions
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студија
3 Months – 100 Years · Оба пола · Ажурирано 21. 10. 2026. · NCT02769975A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Silver Spring
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
- PAREXEL Intl - EPCU-Baltimore, Baltimore
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07868354Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Johns Hopkins University, Baltimore
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06273072A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
- PAREXEL Intl - EPCU-Baltimore, Baltimore
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07855133Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
- Johns Hopkins Center for Health Equity, Baltimore
- Johns Hopkins University Comstock Center, Hagerstown
Тражи се учесник
Узраст од 30 до 70 · Оба пола · Ажурирано 14. 10. 2026. · NCT06364644Mechanisms Underlying Individual Variations of Taste and Smell in Obesity
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04714892Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студијаЗдраве особе су добродошлеНаводи исплату за учеснике
Узраст од 19 до 85 · Оба пола · Ажурирано 13. 10. 2026. · NCT01927783New Heart Imaging Techniques to Evaluate Possible Heart Disease
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 100 · Оба пола · Ажурирано 7. 10. 2026. · NCT01399385Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Annapolis Internal Medicine, LLC, Annapolis
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Barry J. Reiner, MD LLC, Baltimore
Тражи се учесникФаза 3
Узраст од 8 до 18 · Оба пола · Ажурирано 30. 9. 2026. · NCT07253285A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Endo and Metabolic Consultants, Rockville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07564414Physical and Behavioral Traits of Overweight and Obese Adults
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 100 · Оба пола · Ажурирано 28. 9. 2026. · NCT00428987A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- MedStar Good Samaritan Hospital, Baltimore
- MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07321886Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесник
Узраст од 18 до 65 · Оба пола · Ажурирано 18. 9. 2026. · NCT06044935Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 12 до 25 · Оба пола · Ажурирано 17. 9. 2026. · NCT06730113A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bowie
- AURORA-2 Clinical Site, Rockville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Brooklyn
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 55 · Оба пола · Ажурирано 16. 9. 2026. · NCT07723833Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.